摘要
HCV感染是严重的全球公共卫生问题。尽管新一代直接抗HCV药物上市后,丙型肝炎的治愈率显著提高,但一种能有效预防HCV感染的疫苗对于最终消灭丙型肝炎依然非常重要。此文对制约丙型肝炎疫苗研究的因素进行了分析,并对进入临床试验的主要疫苗的类型、特征进行概述。
Hepatitis C virus (HCV) infection is a serious public health problem throughout the world. Although the new direct anti-HCV agents (DAA) significantly increased the cure rate of hepatitis C, an effective prophylactic vaccine is still the most important means to eventually eliminate hepatitis C globally. This paper analyzes the factors that have limited the research and development of hepatitis C vaccine, and summarizes the characteristics of main vaccines that have entered clinical trials.
出处
《国际生物制品学杂志》
CAS
2017年第3期134-138,共5页
International Journal of Biologicals
基金
国家自然科学基金项目(81373235)
关键词
肝炎
丙型
病毒性肝炎疫苗
免疫应答
临床试验
Hepatitis C
Viral hepatitis vaccines
Immune responses
Clinical trial